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Thymus-derived cells of the  mouse,  rat,  and  human  can  be divided,  on  the 
basis of differential expression of cell surface antigens, into phenotypically distinct 
subsets,  and  this phenotypic heterogeneity is correlated with  functional differ- 
ences (1-3).  In the rat, the monoclonal antibody W3/25  (5) has been shown to 
label the T  subset that contains helper cells for B cells (5) and cytotoxic T  cells 
(6,  7)  and  also  cells  that  mediate  graft-versus-host  (GvH)  1 reactivity (5).  The 
monoclonal antibody MRC OX-8 labels the subset that contains suppressor and 
cytotoxic activities (2, 6, 8). 
In this paper a new monoclonal antibody MRC OX-22 is described that labels 
a  subset of the W3/25 ÷ cells in the rat.  Data are presented demonstrating that 
this phenotypic division is correlated with a  functional one, with cells mediating 
help for B cells and those mediating GvH reactivity in different T  cell subsets. 
Biochemical studies of the MRC OX-22 antigen demonstrate that it reacts with 
the high molecular weight form of the rat leukocyte-common antigen (L-CA). 
Materials and Methods 
Rats 
Inbred rats from the specific pathogen-free unit at the MRC Cellular Immunology Unit 
were used.  The strains  were PVG/c (RTlC;  Iglb),  PVG-1 a (RTlC;  Igla), and (PVG  × 
DA)F~ (RTV  ×  RTI").  PVG/c  and  PVG-I" are  congenic strains  that  differ in  their 
immunoglobulin light chain allotypes. Irradiations were performed using a  137Cs source 
at 94 rad/min (Gammacel; Atomic Energy of Canada). 
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Abbreviations used in this paper:  BSA,  bovine serum albumin; DAB, Dulbecco's A + B medium; 
DFP, diisopropylfluorophosphate; DNP-BGG, dinitrophenyl bovine gamma globulin; FACS, fluores- 
cence-activated cell sorter; GvH, graft-versus-host; L-CA, leukocyte-common antigen; MHC, major 
histocompatibility  complex; NCS, newborn calf serum; NP-40, Nonidet P-40; PMSF, phenylmethyl- 
sulphonyl fluoride; RAM, rabbit F(ab')~ anti-mouse Ig antibody; RAM-FITC, fluorescein isothio- 
cyanate-conjugated RAM; SDS-PAGE, sodium dodecyl sulphate-po|yacrylamide gel electrophoresis; 
TDL, thoracic duct lymphocytes. 
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A~tibodies 
MRC  OX-22  monoclonal antibody was  derived  by a  fusion  of spleen  cells  from  a 
BALB/c mouse immunized with phytohemagglutinin-activated rat lymph node cells with 
NS 1 myeloma cells. Rat lymph node cells were cultured in 10 gg/ml phytohemagglutinin 
type V from Phaseotus vulgaris (Sigma Chemical Co., Detroit, MI) in RPMI 1640 medium 
plus  5%  DA rat serum,  2.5  x  10 -5 M  merca~toethanol and  2 mM glutamine for 3 d. 
BALB/c mice were immunized twice  with  10  blast  cells per mouse intraperitoneally at 
an interval of 10 d, and 6 wk later were immunized again with blast cells intravenously. 3 
d  later the spleen cells were fused with the NS 1/1.Ag4.1  cell line and hybrids selected 
according to the procedures of Galfre and Milstein  (9). Cultures with  hybrid cells were 
screened  for antibody with  the  indirect  binding assay  on  blast  cells, and  clones were 
obtained from positive cultures by dilution cloning with rat thymocytes as feeders. The 
positive cultures were recloned at intervals and after growing in  mice as ascites.  MRC 
OX-22 was found to be of lgG~ class by formation of precipitin in agar using rabbit anti- 
mouse IgGl antiserum,  kindly provided by M.  Parkhouse and rabbit anti-mouse IgGz~ 
and  IgG2b serum  from  Miles Laboratories Ltd.  Other  mouse monoclonai anti-rat  cell 
antibodies used were: W3/13 and W3/25 (4); MRC OX-7 (10);  MRC OX-8 (2); MRC 
OX-12 (11),  and MRC OX-19 (6). Rabbit anti-mouse (RAM) F(ab')2  and its fluorescein 
isothiocyanate (FITC) conjugate (RAM-FITC) were prepared as described previously (4). 
Rat anti-rat  1  a allotype was as  described in  (11)  and  rabbit  anti-rat  F(ab')2  as  in  (12). 
Antibodies were labeled with  '25I by the chloramine T  method to a  specific  activity of 
~25 uCi/ug (10). 
Media 
Cells were suspended in  Dulbecco's A  +  B medium (DAB),  with  either 2%  newborn 
calf serum (NCS) or 0.2% bovine serum albumin (BSA).  10 mM sodium azide was added 
to cells for fluorescence-activated cell sorter (FACS) (B-D FACS Systems, Sunnyvale, CA) 
analysis and sorting. 
Cells 
Thoracic duct lymphocytes (TDL) were collected overnight into DAB containing 20 
IU/ml heparin at  4°C.  Spleen  cells  were  obtained by pressing spleens  through a  wire 
gauze  into  ice-cold  DAB/NCS,  and  after  washing,  erythrocytes and  dead  cells  were 
removed by suspending the cells in 5 ml distilled  water for 5 s after which isotonicity was 
restored by the addition of 5 ml  1.8%  NaCI.  The dead cells were clumped and filtered 
on a small cotton wool plug and red cell ghosts were removed by washing cells twice by 
centrifugation. 
Cell Separation by Rosetting 
T  cells or B cells were isolated from rat TDL or splenocytes by depletion of cells that 
rosetted with sheep erythrocytes coated with anti-rat Ig or W3/13 antibody, as described 
by Mason (13). 
Cell Sorting Using a FACS H 
2.5 x  108 lymphocytes were incubated with the appropriate monoclonal antibody for 
1 h at 4°C, washed twice in DAB/NCS, and then incubated with RAM-FITC for 1 h also 
at 4°C. After a final wash they were suspended in 15 ml DAB/NCS/azide. Red and dead 
cells were excluded by the appropriate scatter gating. 
Assays 
GvH Assa~,s.  The popliteal lymph node assay was used exactly as described by Ford et 
al. (14). Lethal GvH disease  was induced by the protocol described in (13). Details of cell 
doses for these assays are given in the main text. 
Helper Cell Assay.  An adoptive transfer method was used in which sorted lymphocytes 
from animals  primed  with  dinitrophenyl-bovine gamma globulin  (DNP-BGG) were  in- 
jected intravenously together with 1 mg of DNP-BGG into irradiated syngeneic recipients SPICKETT ET AL.  797 
(700 rad) (5). Serum was collected 7 d later and assayed for anti-DNP antibody. 
Binding Assay  for Anti-DNP Antibody.  Rat sera were diluted in DAB/2% NCS and 50- 
/~1 aliquots were assayed in triplicate at 4°C for binding to DNP-BGG adsorbed to wells 
of 96-well polyvinyl chloride Linbro plates (Linbro Chemical Co., Hamden, CT). Bound 
antibody was detected by a second incubation with  50 ttl of ~5I-rabbit anti-rat F(ab')2 
antibody with sera from PVG/c donors or ~5I-rat anti-rat  1  a allotype antibody for sera 
from PVG-1 a donors. To prepare the plates 50 #1 per well of DNP29-BGG at 200 #g/ml 
in  DAB/0.2%  NCS  was  left in  the  wells  overnight followed by washing  with  water, 
incubation for 1 h with 10% rabbit or human serum in DAB/10 mM NAN3, and washing 
again with water. In the assays both incubations were for 1 h with 3 washes  with DAB/ 
0.2% NCS after each step. Finally, the plates were air-dried, the wells were cut off with a 
hot wire, and ~5I was counted with an LKB Rackgamma counter (LKB Instruments, Inc., 
Rockville, MD). 
Quantitative Absorption Assays  with Cells and Tissue  Homogenates (15).  MRC OX-22 ascites 
fluid was  diluted  1:25,000  and  aliquots  were  incubated at  4°C  for  2  h  with  various 
dilutions  of cell  suspensions  of spleen,  thymus,  and  erythrocytes, or homogenates of 
kidney and liver. The erythrocytes and kidneys were derived from animals irradiated 3 d 
before with 950 rad to remove lymphocytes. Then the mixtures were centrifuged and 
the supernatants assayed for residual antibody by the indirect binding assay using trace 
conditions (15, 16). 
Localization of Antigens in Cryostat Sections 
Cryostat sections of rat brain, spleen, kidney, skin, and thymus were stained for cells 
reactive with monoclonal antibodies MRC OX-22, MRC OX-18 (mouse anti-rat class  1 
major histocompatibility complex (MHC) antibody [17]) and MRC OX-21  (mouse anti- 
human C3b inactivator antibody [ 18]) using the immunoperoxidase method described by 
Barclay (19).  The peroxidase-conjugated rabbit Fab anti-mouse Ig reagent was the kind 
gift of Dr. A. N. Barclay (19). 
Biochemical Analysis 
For analysis of surface-labeled glycoproteins, TDL were labeled with [3H]borohydride 
after oxidation with periodic acid (20, 21), solubilized, and subjected to affinity chroma- 
tography exactly as in (22) except that  1 mM phenylmethylsulfonyl fluoride (PMSF) was 
used as a  proteolytic inhibitor rather than diisopropylfluorophosphate (DFP).  Samples 
were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
with radiolabeled material visualized by fluorography, as described in (22). 
Results 
Tissue Distribution of Cells Binding MRC 0X-22 Monoclonal Antibody 
Flow Cytofluorograph Analysis.  Cells were incubated with MRC OX-22 mono- 
clonal antibody followed by fluorescein-conjugated rabbit F(ab')~ anti-mouse Ig 
antibodies,  and  binding  was  analyzed  by  flow cytofluorography. As  shown  in 
Table  I  and  Fig.  1,  a  total  of 84%  of cells were labeled and  the  fluorescence 
histogram  showed  three populations,  one  unlabeled,  one  weakly positive, and 
one strongly  so.  TDL  were  incubated  with  MRC  OX-22  antibody along  with 
other  mouse  anti-rat  monoclonal  antibodies  to  T  subsets  and  the  results  are 
presented in Table I  and were used to construct the subpopulation diagram in 
Fig. 2. MRC OX-22 antibody labels virtually all B cells and cytotoxic/suppressor 
cells but only % of the W3/25 + T  cell subset. The heavily labeled MRC OX-22 + 
cells are mainly B cells since labeling of cells with MRC OX-22 and MRC  OX- 
12 (anti-kappa) together increased the fluorescence of these bright cells but not 
the weakly labeled ones. Co-labeling with MRC OX-19 (pan T) had the opposite 798  FUNCTIONAL  HETEROGENEITY  OF  RAT  HELPER  T  CELLS 
TABLE  ] 
Percentages of Rat TDL and Bone Marrow Cells Labeled by Mixtures 
of MRC 0X-22 and Other Mouse Anti-Rat Monoclonal  Antibodies 
Antibodies 
(subset labeled) 
Percentage of cells la- 
beled 
Bone mar-  TDL 
row 
MRC OX-22 only  84  46.4 
MRC OX-12 (anti-kappa chain of rat Ig)  50.4  12.4 
MRC OX-19 (pan T  cell)  46.1  2.7 
MRC OX-8 (T¢/0  6.9  ND 
W3/25 (Th)  37.1  ND 
W3/13 (pan T  cell, granulocytes)  ND  40.3 
MRC OX-7 (anti-rat Thy-1.1)  ND  52.8 
MRC OX-22 +  MRC OX-12  84.8  49.6* 
MRC OX-22 +  MRC OX-19  93  44.0 
MRC OX-22 +  MRC OX-8 +  MRC OX-12  85  ND 
MRC OX-22 +  W3/25  93.6  ND 
MRC OX-22 +  W3/13  ND  73.8 
MRC OX-22 +  MRC OX-7  ND  53.0 
The monoclonal antibodies in the table were used either singly or in 
mixtures to label rat TDL and bone marrow cells.  After 1 h incubation 
the cells were washed, incubated for a further 1 h with RAM-FITC, and 
examined on the FACS. The percentage of labeled cells was obtained 
from histograms of 5  ×  104 cells.  Using W6/32  monoclonal antibody, 
which does not react with normal rat tissues, as a negative control, <1% 
of TDL or bone marrow cells were labeled. ND, not determined. 
* In two other experiments, MRC OX-22 plus MRC OX-12 was exactly 
the same as MRC OX-22 alone, indicating that all surface Ig  ÷ cells were 
also MRC OX-22  ÷. 
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FIGURE  1.  Fluorescence histograms of TDL, bone marrow, spleen, and thymus cells labeled 
with monoclonal antibody MRC  OX-22.  Single-cell suspensions were incubated with MRC 
OX-22  monoclonal antibody, washed, and  then  incubated with  RAM-FITC.  Fluorescence 
histograms were obtained on the FACS using l0  b cells.  Both scales are linear. (A) TDL, (B) 
spleen, (C) bone marrow, (D) thymus. 
effect (data not shown).  The  pattern  of labeling on spleen cells was essentially 
identical to that of TDL but only 2.1% of thymocytes were labeled by MRC OX- 
22 antibody (Fig.  1). 
Analysis of bone marrow revealed a bimodal profile with 46% of cells labeled 
(Fig. 1, Table I). ¾ of these cells were unlabeled by W3/13 monoclonal antibody, 
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FIGURE 2.  Relationship of subsets of lymphocytes and bone marrow cells, defined by MRC 
OX-22 antibody, to previously defined lymphocyte subsets. 
most marrow lymphocytes. In contrast, all of the MRC OX-22 + cells were also 
labeled by MRC OX-7 antibody (Thy-1 +), which labels stem cells and the marrow 
lymphocytes that are thought to be immature B cells (24).  It thus seems likely 
that MRC OX-22 antibody labels most cells of the B lineage in the marrow as 
well as in the periphery. 
Detectio~ of  MRC 0X-22 + Cells on Cryostat Sections.  Immunoperoxidase staining 
of cryostat sections of spleen revealed a reaction pattern that was consistent with 
that obtained by flow cytofluorography in that, although both B and T  cells were 
labeled, the staining of the B areas was more intense than that of the T  areas. 
The staining pattern  in  the thymus was unique in  that,  though few cells were 
stained, the majority of these positive cells were found at the edge of the medulla, 
which was defined by staining with MRC OX-18 antibody (Fig. 3). Additionally, 
there were labeled cells scattered through the cortex with an apparently random 
distribution.  Staining of sections of liver, brain,  and skin  failed to detect any 
antigen  present,  while  in  the  kidney very faint staining was seen  only in  the 
glomeruli (the significance of this latter finding is doubtful). 
Quantitative  Absorption  Analysis.  Rat  erythrocytes,  splenocytes,  thymocytes, 
and homogenates of kidney and liver were used to absorb MRC OX-22 antibody, 
and  the  completeness of absorption  was  determined by assaying the  residual 
antibody on TDL using a cellular radioimmunoassay. Thymocytes had 2.3% of 
the absorptive capacity of spleen cells, but erythrocytes, kidney, and liver failed 
to produce any absorption even when weights of wet tissue were used that were 
100  times that of the amount of spleen needed to give complete absorption of 
the antibody.  Thus the absorption  data is fully consistent with  the results for 
antigen distribution by FACS analysis and from the staining of cryostat sections. 800  FUNCTIONAL  HETEROGENEITY  OF  RAT  HELPER  T  CELLS 
FIGURE 3.  Serial cryostat sections ofrat thymus stained with MRC OX-22 and MRC OX-18 
(anti-MHC class I  antigen) monoclonal antibodies. Ethanol-fixed cryostat sections of thymus 
were incubated with  MRC  OX-22  or  MRC  OX-18  antibodies, washed,  and incubated with 
peroxidase-conjugated rabbit Fab anti-mouse IgG. After a further wash the presence of bound 
enzyme  was  revealed  by  incubating  the  section  in  diaminobenzidine  in  the  presence  of 
hydrogen peroxide (19). (B) The MRC OX-18 antibody stains the medulla (M) more heavily 
than the cortex (C).  The MRC OX-22  ÷ cells are found predominantly as a ring of cells lying 
just within the medulla (A). MRC OX-21 antibody (anti-human Csb inactivator) was used as a 
negative control and gave no staining (data not shown). 
Biochemical Characterization  of the MRC 0X-22 Antigen 
The sialic acid of glycoproteins of TDL was labeled with 3H by reduction with 
[SH]Na borohydride after oxidation with periodic acid (20). Membrane molecules 
were  solubilized in  1%  Nonidet  P-40  (NP-40)  detergent and  the  extract  was 
passed  through an  MRC  OX-22  antibody affinity column.  A  glycoprotein of 
220,000 apparent mol wt was eluted from the column (Fig. 4).  The binding of 
this glycoprotein was specific since this band was not retained on control columns 
(data  not  shown).  The  220,000  tool wt glycoprotein also binds to an affinity 
column containing MRC  OX-1  antibody specific for L-CA (Fig.  4).  Bands at 
200,000,  190,000,  and  180,000  tool wt also bind to the MRC OX-1  column. 
These lower tool wt bands are thought to be derived from T  cells (25),  and in 
Fig. 4 it is clear that the 190,000 and 180,000 mol wt bands do not bind to the 
MRC OX-22 column. However, the 200,000  mol wt band does appear to bind 
at least in part to MRC OX-22 antibody; whether this might be the T  cell form 
of the MRC OX-22  antigen remains to be established. Also there appeared to 
be some bands of "~220,000 tool wt that were bound by the MRC OX-1  but not 
the MRC OX-22  column, and the origin of these also requires further investi- SPICKETT  ET  AL.  801 
FIGURE 4.  SDS-PAGE of SH-labeled glycoproteins purified on MRC OX-22 or MRC OX-1 
affinity columns.  9  x  108  TDL  were oxidized  with  periodate and  reduced  with  10  mCi 
NaB[nil]4.  The membrane proteins were solubilized in 6 ml 1% NP-40 and after centrifugation 
aliquots of the extract were passed through MRC OX-22 and MRC OX-1 affinity columns (5 
ml with 10 mg IgG/ml Sepharose 4B). The columns were washed with 0.5% deoxycholate in 
10 mM Tris HCI, pH 8, and bound material was then eluted with the same buffer plus 0.05 
M diethylamine HC1, pHI 1.5.  The gels show electrophoresis of trichloroacetic acid-precipi- 
table  material  from  starting  extract  (unfractionated),  extract  passing  through  the  column 
(passed),  and eluted materials (eluted). The unfractionated and passed  tracks  used material 
derived from 75 t*l of starting extract, whereas the eluted tracks used material from 150 #l of 
starting extract. 
gation. 
The clear point from Fig. 4  is that  MRC OX-22 antibody reacts mainly with 
the high tool wt form of the L-CA. Proof that the MRC OX-22 glycoprotein is 
part  of the  L-CA  complex  is  given  in  Table  II,  which  shows the  counts  per 
minute of 3H-labeled glycoproteins eluted from MRC OX-1  and  MRC 0X-22 
columns run in series. When the MRC OX-1 column preceded the MRC OX-22 
column, almost no cpm were eluted from the second column, whereas when the 
MRC OX-22 column was first, it bound ~20%  of the radioactive material that 
can be bound by the MRC OX-1 column. 
Functional Studies 
Previous studies have shown that  cells which  mediate helper functions for B 
cell responses and  the GvH reaction  as measured  by the popliteai  lymph node 
assay are found exclusively in a  T  cell subset that is uniformly labeled by W3/ 
25 antibody. Labeling with MRC OX-22 antibody subdivides the W3/25 + cells 
(Fig.  1) and functional  studies were carried out to see whether this subdivision 
correlated with different functional activities. 
GvH Reactivity  and  GvH Disease.  The  results  in  Fig.  5  shows that  the  cells 
which mediate popliteal lymph node enlargement  are all labeled by MRC OX- 
22 antibody and  that  the unlabeled cells do not show this activity. This is true 
whether the sorted cells were injected in doses proportional to the frequency of 
MRC OX-22- and MRC OX-22  + cells in the original parental TDL (physiological 
doses) or if cell doses were adjusted so as to give all recipients equal numbers of 
T  cells (equal T  cell doses). 
In  contrast  to  GvH reactivity as demonstrated  by the popliteal  lymph  node 802  FUNCTIONAL  HETEROGENEITY  OF  RAT  HELPER  T  CELLS 
TABLE  II 
Binding of 3H-labeled Glycoproteins to MRC OX-1 (anti-L-CA) and 
MRC 0X-22 Affinity Columns 
3H-glycoprotein eluted 
Order of columns in series 
MRC OX-1  MRC OX-22 
MRC OX-22  MRC OX-1 
cpm 
First column  1.6 x  106  2.8 x  105 
Second column  2.7 x  l04  1.4 x  106 
7 x  I 0 s TDL were oxidized with periodic acid and labeled with  10 mCi 
of NaB[SH]4. Membrane proteins were solubilized in 6 ml 1% NP-40 and 
2.4-ml aliquots of this extract  were passed  through  two sets of affinity 
columns containing MRC OX-1  and  MRC OX-22 antibody  in series as 
shown above (each column was 5 ml with  I0 mg IgG/ml Sepharose 4B). 
On each set of columns was loaded 8.8 x  106 cpm of trichloroacetic acid- 
precipitable radioactivity, and the amount  unbound  by the columns was 
6.7 x  106 cpm for the MRC OX-22/MRC OX-1  experiment and 7.1  x 
106 cpm for the MRC OX-1/MRC OX-22 experiment. The columns were 
washed with 0.5% deoxycholate, 10 mM Tris HCI, pH 8, buffer and then 
eluted with the same buffer plus 50 mM diethylamine HCI, pH 11.5. The 
trichloroacetic acid-precipitable counts were determined and are shown 
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FIGURE 5.  Ability of MRC OX-22  ÷ and MRC OX-22- subsets of parental strain rat TDL to 
mediate popliteal lymph node enlargement in Fn recipients. Parental strain TDL were sepa- 
rated  on  the  FACS into  MRC  OX-22- and  MRC  OX-22 ÷ subsets.  These  cells were  then 
injected  into  the  footpads  of F~  hybrid  rats  and  the  popliteal  lymph  nodes  removed  for 
weighing 7 d later (14).  E, experiments in which the T  cell dose for all groups was identical; 
P, experiments in which the subpopulations were used in their physiological ratios (see text) 
based on a TDL dose of 107 cells. Purities were >99% for both fractions. Results are given as 
means ±  standard deviation. 
assay,  lethal  GvH  disease  can  be mediated  by both  the  W3/25  +  and  MRC  OX- 
8 + T  cell subsets  (13).  Parental  TDL  were  fractionated  after  labeling with  MRC 
OX-22  antibody  and  injected  into  sublethaily  irradiated  F1  hybrids.  Only  the 
recipients of MRC  OX-22 ÷ cells developed  the erythema,  ruffled fur, and  weight SPICKETT  ET  AL.  803 
loss characteristics of GvH disease (Fig. 6). Rats given MRC OX-22- cells gained 
weight and remained  as healthy as those given only saline.  These results dem- 
onstrate that  W3/25 +,  MRC OX-22- cells are unable to mediate  GvH disease 
but do not exclude the possibility that the GvH disease observed when unfrac- 
tionated  W3/25 +  cells  are  used  (13)  arises  as  a  consequence  of  a  cell-cell 
interaction  between the  MRC  OX-22-  and  MRC  OX-22 + components of the 
W3/25 + population. However, when W3/25 +, MRC OX-22 + were assayed alone 
for  their  ability  to  cause  lethal  GvH  disease,  recipients  did  develop  disease, 
indicating that synergy with W3/25 +, MRC OX-22- cells was not required (data 
not shown). 
T Help for Anti-hapten Antibody Responses.  Table III (experiment  1) shows the 
results  of an  experiment  designed  to assay the  ability of MRC  OX-22-  cells, 
MRC OX-22 + cells, or a  mixture  of the two to adoptively transfer a  secondary 
antihapten  response  to  sublethally  irradiated  recipients.  As  the  table  shows, 
neither fraction alone produced a response comparable to that of unfractionated 
TDL,  but a  mixture,  in  physiological proportions,  of the  two fractions  was as 
active as unfractionated cells. 
Because the MRC OX-22 antibody was known to label most, if not all, B cells 
(Fig. 2) the synergy observed in the experiment described in Table III suggested 
that  the B memory cells were in the MRC OX-22 + fraction and helper T  cells 
for B  cell responses in  the  MRC OX-22- one.  To test this conclusion directly 
MRC OX-22- and MRC OX-22 ÷ cells, from primed donors, were supplemented 
with  primed  B  cells,  and  the  ability  of these  mixtures  to  adoptively  transfer 
secondary antihapten  responses was assayed. The results, presented in Table III 
(experiment  2), showed that the MRC OX-22- cells were much more active in 
providing B cell help than were the MRC OX-22 + cells. However, the MRC OX- 
22 + cells appeared to provide some help and the reconstitution with MRC OX- 
22- cells was not complete compared with the response obtained from unfrac- 
tionated TDL. This result was obtained from three similar experiments. Further 
comments on this result are deferred to the Discussion. 
Cells  Mediating  Allogeneic  Suppression  of  Antibody Synthesis  are  MRC  0X- 
22 +.  Under appropriate  conditions the induction  of GvH disease in  F~ rats is 
accompanied  by  a  profound  suppression  of antibody  synthesis  (2,  5).  This 
allogeneic suppression is mediated by MRC OX-8 ÷ cells (2),  which form --, 10% 
of all  cells in  TDL.  Because the  percentage  of these cells is  so small,  it is not 
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FIGURE 6.  Inability of MRC OX-22- cells to mediate GvH disease. MRC OX-22- and MRC 
OX-22  + subpopulations of parental strain rat TDL, isolated on the FACS, were injected in 
physiological ratios into subletbally irradiated F~  rats. Rats were weighed on alternate clays 
thereafter. #, death of a rat from GvH disease. 804  FUNCTIONAL HETEROGENEITY OF  RAT  HELPER  T  CELLS 
TABLE  III 
Synergy Between MRC 0X-22- and MRC 0X-22 + Cells in Antihapten 
Antibody Responses 
Experi-  Cells transferred  Percent relative 
ment  antibody titer  ° 
106 OX-22-  8.1 
8 × 106 OX-22 +  11.3 
106 OX-22- + 8 × 106 OX-22  +  138 
10  7 TDL  100 
5 X 106 B cells  0.6 
1  ×  10 7 B  +  106 OX-22-  71 
5×  106B+8x  106OX-22 ÷*  14 
107 TDL  100 
Sublethally irradiated  syngeneic recipients were injected with TDL or 
subpopulations thereof from DNP-BGG-primed donors and were chal- 
lenged with the priming antigen at the time of cell transfer.  Anti-DNP 
antibody titers were determined 7 d later. There were two animals in 
each group for experiment 1 and three per group in experiment 2. In 
experiment 1 MRC OX-22- cells were 99.8% pure and MRC OX-22 ÷, 
99.2% pure. In experiment 2 the corresponding results were 99.9% and 
99.3%, respectively. The B cells were 96% pure as judged by percent of 
surface Ig cells. The MRC OX-22  + cells were isolated on the FACS and 
the B cells for experiment 2 by indirect rosette depletion of primed TDL 
using W3/13 monoclonal antibody. 
* Anti-hapten antibody titers are expressed as a percentage of the control 
response produced by unfractionated  TDL. 
* The 8 ×  106 MRC OX-22  + cells contained ~5 x  106 B cells. 
possible to prove by the type of population analysis in Table I that all MRC OX- 
8 + cells are also MRC OX-22 ÷. To verify that the cells responsible for allogeneic 
suppression were MRC OX-22 +, sublethally irradiated Fa rats were given hapten- 
carrier-primed F~ spleen cells and either unfractionated,  primed parental TDL 
or parental  TDL  that  had  been  fractionated  on  the  FACS  into  MRC  OX-22- 
and  MRC  OX-22 + subsets.  The  allogeneic suppressive activity of the  parental 
spleen  cells  was  wholly  contained  within  the  MRC  OX-22 +  population  (Table 
IV). This experiment was repeated with the same result. 
Phenotype of the Memory B  Cell.  Memory B  cells in rat TDL  constitute only a 
few  percent  of all  the  cells  present  (26),  so  although  the  population  analysis 
shown  in  Table  I  indicated  that  the  great majority of all  B  cells in  TDL  were 
MRC OX-22 +, this did not conclusively demonstrate that the memory B cell also 
expressed  this  antigen.  Further,  the  small  but  significant  antibody  response 
observed (Table III) when MRC OX-22- cells were transferred into sublethally 
irradiated hosts was of uncertain origin, since, in principle, the T  helper cells in 
the population  could have been collaborating with any donor B cells present in 
the  MRC OX-22-  inoculum  or with radio-resistant  B  cells in the  host (27).  To 
determine directly whether any B memory cells were MRC OX-22-, an adoptive 
transfer experiment was carried out using hapten-carrier-primed TDL  from  l a 
ligbt chain allotype donors and sublethally irradiated  congenic recipients of the 
1  b allotype (11).  To ensure that T  helper cells were not limiting in the assay, all 
recipients of MRC  OX-22-  cells and  MRC  OX-22 ÷ ceils also received  hapten- SPICKETT  ET  AL. 
TABLE  IV 
Phenotype of the Cell Responsible  for Suppression of Antibody Synthesis 






2.3 x  107 F~ spleen cells +  1 x  l0  s P OX-22- TDL  95 
2.3 ×  10  ~ F, spleen cells +  8 X 106 P OX-22  ÷ TDL  16.0 
2.3 ×  l0  T Fl spleen cells +  107 P TDL  6.5 
2.3 ×  107 F~ spleen cells only  100 
DNP-BGG-primed F1 spleen cells were transferred either alone or with 
various populations of primed parental (P) TDL  isolated on the FAC8, 
into sublethally irradiated F1 recipients. All cell recipients were challenged 
with the primary antigen at the time of cell transfer and the  1  = allotype 
component (i.e., that derived from the F~ cells) of the anti-DNP response 
assayed 7 d later. Purities of MRC OX-22- and MRC-22 ÷ cells were >98%. 
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FIGURE 7.  The phenotype of the B memory cell. MRC OX-22- and MRC OX-22  + fractions 
of TDL from  I a light chain allotype donors primed to DNP-BGG were transferred, together 
with primed T  cells from donors of the same allotype into sublethaUy irradiated  I b allotype 
recipients.  Control  rats  received  primed  TDL  or  primed  T  cells and  all  recipients were 
challenged at the time of cell transfer with DNP-BGG. The 1  a allotype component of the anti- 
DNP response was determined 7 d later using an allotype-specific solid phase radioimmunoas- 
7  6  6  6  say. (<>) 10  primed TDL; (O) l0  MRC OX-22- plus 5 x  10  T  cells; (0) 8.5 x  10  MRC OX- 
22  ÷, 5 x  10BT cells; (V) 5 x  106 T  cells alone; (O) negative serum control. Purities for MRC 
OX-22- and  MRC  OX-22  + were >99%,  for T  cells (purified by indirect rosette depletion 
using MRC OX-12 antibody (11, 13), 93.4%. The low antibody titer observed with the purified 
T  cells is accurately  accounted  for by the  residual B  cells in this preparation.  Results are 
presented as means with ranges for two rats per group for TDL and T  alone; three rats per 
group for MRC OX-22- and MRC OX-22 + groups. 
carrier-primed T  helper cells from 1  a allotype donors. The solid phase radioim- 
munoassay was made specific for antihapten antibody of donor allotype by using 
125I-iabeled anti-1 a allotype antibody. As Fig.  7  shows, the MRC OX-22 + cells, 
when provided with T  cell help, provided a response equal to that of unfraction- 
ated TDL, while the MRC OX-22- population was completely inactive. A second 806  FUNCTIONAL  HETEROGENEITY  OF  RAT  HELPER  T  CELLS 
experiment gave the same result. 
Discussion 
The  principal  findings  of this  work  are  that  the  MRC  OX-22  monoclonal 
antibody recognizes the high molecular weight form of the rat L-CA and defines 
a  new functional  subset of T  cells.  In rat  (25),  mouse (28), and  man  (29),  the 
molecular weight of L-CA varies in a similar manner according to the cell type 
from which it is extracted.  In the rat, the predominant forms of the L-CA from 
thymocytes,  T  cells,  and  B  cells run  on  SDS-PAGE  with  apparent  molecular 
weight  of  170,000,  190,000  (multiple  bands),  and  220,000  respectively (25). 
These different forms have different carbohydrate structures,  as shown by the 
differences in  binding  of peanut  and  soybean lectin  but it  is possible that  the 
protein is identical for the different types. In the present analysis on glycoproteins 
from mixtures of T  and B cells, MRC OX-22 antibody was seen to bind mainly 
to the high molecular weight form of L-CA, which was previously thought to be 
characteristic of B cells. However, MRC OX-22 antibody labels 2A of T  cells at 
low levels in addition to its heavy labeling of B cells, and this suggests that either 
T  cells express the high molecular weight form of L-CA as well as the dominant 
bands around  190,000 tool wt, or that a  minor band at 200,000 mol wt, which 
also appeared to bind to MRC OX-22 antibody, is the T  cell product. Obviously 
more work on the molecular weight heterogeneity of T  cell L-CA is needed as 
is analysis of the protein or carbohydrate nature of the antigenic variation. 
Comparison  of the  MRC OX-22  data with the results of Dalchau and  Fabre 
(30,  31)  show  that  rat  and  human  L-CA  have  similar  patterns  of antigenic 
heterogeneity.  Dalchau and Fabre described a  monoclonal antibody that reacts 
with the high molecular weight form of L-CA and labels all B cells, all T  cells of 
the cytotoxic/suppressor phenotype (OKT8 ÷ cells), l/s of T  helper cells (OKT4 + 
cells), and a  small percentage  of thymocytes (30,  31).  Apart from the fact that 
this antibody labels only  ½  of the OKT4 + cells in  man,  whereas MRC OX-22 
labels 2/3 of W3/25 + cells in the  rat,  these tissue distributions  are identical.  In 
the mouse, the  2C2,  14D10, and  14.8 monoclonal antibodies all  recognize the 
high molecular weight form of the L-CA and are expressed on Lyt-2  ÷ cells (32- 
34). However, except in the lpr mouse, the antigen recognized by those antibodies 
is not expressed on Lyt-2- cells that seem to be the homologue of rat W3/25 + 
cells. 
The  experiments  on  the  fractions  of the  MRC  OX-22- and  MRC  OX-22 + 
subsets of rat  TDL  revealed a  hitherto  unknown  heterogeneity  in  the  T  cell 
subset that expresses the W3/25 antigen. This is seen in the correlation between 
rat  T  cell  subsets and  functions  summarized  in  Table  V.  As the  table  shows, 
labeling  with  MRC  OX-22  antibody  clearly  distinguishes  W3/25 ÷  cells  with 
helper activity for B cells (W3/25 +, MRC OX-22-) from those showing alloreac- 
tivity in the popliteal lymph node assay (W3/25 ÷, MRC OX-22+). The question 
remains  as  to  whether  the  W3/25 ÷,  MRC  OX-22 + cells play any  role  in  the 
helper  effect.  Although  the  MRC  OX-22 ÷ ceils,  isolated  on  the  FACS,  were 
~99% pure, a  1% contamination  with MRC OX-22-cells represents  ~10%  of 
all  the  cells of this  phenotype  in  the  unseparated  population,  so the  apparent 
helper activity of the  MRC OX-22 + cells may be artifactual.  However, in vitro 
studies have produced evidence for the existence of two types of T  helper cell: SPICKETT ET  AL. 
TABLE  V 
Functions of MRC OX-22-positive and -negative T Cell Subsets 
807 
W3/25  ÷,  W3/25  ÷,  OX-8  ÷,  Surface Ig  +, 
OX-22-  OX-22  ÷  OX-22  ÷  OX-22  ÷ 
T helper for B cells  +  +  -  - 
GvHR  -  +  -  - 
GvH disease  -  +  ND  °  - 
T suppressor  -  -  +  - 
B cell (including B memory cell)  -  -  -  + 
"Lethal GvH disease can also be caused by MRC OX-8  ÷ cells (13) but it remains to be formally 
demonstrated that these cells express the MRC OX-22 antigen. 
one helping B cells in a one-to-one interaction (monogamous help) and the other 
providing nondiscriminatory (polyclonal) help via a soluble mediator (35), and it 
cannot be excluded that the MRC OX-22 antigen distinguishes these two types 
of helper cells. This possibility is supported by the observation that full immune 
responsiveness was obtained only when both MRC  OX-22 + and  MRC  OX-22- 
fractions of the W3/25 ÷ population were transferred together with B cells into 
irradiated recipients (Table III).  In any event it is clear that if W3/25 ÷,  MRC 
OX-22 + cells do provide B cell help, they are <10% as potent on a per cell basis 
as W3/25 +, MRC OX-22- cells (Table III). 
In  man and  mouse, monoclonal antibodies have been described that label  B 
cells and subsets  of T  cells (31-34,  36).  With the exception of the monoclonal 
antibody TQ1, described by Reinherz et al. (36), and the monoclonal antibody 
of Dalchau  and  Fabre  (31),  none of these  antibodies  appears  to divide  the  T 
helper  subset  and  functional  studies  have  been  made  only  with  TQ1.  The 
T4+TQ1 -  T  cell subset  in  man  shows  similarity with the W3/25 +,  MRC  OX- 
22- population in the rat in that both provide help for B cells but, as with W3/ 
25 ÷, MRC OX-22 + cells, the T4÷TQ1 + subset showed some weak helper activity. 
No  biochemical  characterization  of the  TQ1  antigen  has  been  made  and  the 
homology between  the  subsets  of T  helper  cells  in  the  two species  is  not  yet 
firmly established. 
The observation  that although  most peripheral  T  ceils were  MRC  OX-22 +, 
most thymocytes were not labeled by this antibody suggests that the few MRC 
OX-22 + cells in the thymus were mature cells.  "~50% of these cells were found 
at the edge of the medulla  where thymocytes are believed to leave the thymus 
(37), but because small numbers of peripheral T  cells migrate back to the thymus 
medulla  (38),  it cannot be ruled out that  these MRC  OX-22 + cells are T  cells 
entering the thymus rather than  mature thymocytes leaving it.  The MRC OX- 
22 + cells  in  the  thymic cortex  made  up  the  remaining  50%  of cells  with  this 
phenotype. These cells are  unlikely to be of peripheral  T  cell origin  (38) and 
their presence raises the possibility that, rather than involving an intramedullary 
phase, thymocyte maturation may go on to completion within the thymic cortex. 
Clearly it would be of value to know if these cells express both the W3/25  and 
MRC OX-8 antigens, as do the great majority of rat cortical thymocytes (17), or 
whether they express only one or another of these markers, as do most mature 
T  cells. 
The  MRC  OX-22  antibody is  potentially of value in  the isolation of the rat 
bone marrow stem cell. As Table I  shows, almost all Thy-1 + bone marrow cells 808  FUNCTIONAL HETEROGENEITY OF  RAT  HELPER T  CELLS 
also express the MRC OX-22 antigen and it is known that rat stem ceils are to 
be found amongst the Thy-1 + population (24).  If it turns out that stem cells are 
MRC OX-22-,  then the isolation of Thy-1 ÷, MRC OX-22-  cells will provide a 
highly enriched source of these cells. 
Summary 
A  mouse monoclonal antibody (MRC OX-22)  is described that labels rat T 
cells  which  mediate graft-versus-host reactions and  those  responsible  for  the 
suppression of  antibody synthesis in hosts undergoing these reactions. In contrast, 
most of the T  cells that provide help for B cells are MRC OX-22 negative. These 
results, taken together with those published previously, demonstrate that the rat 
contains at least three phenotypically and functionally distinct subsets of T  cells. 
The MRC OX-22 antibody also labels all B cells,  50% of bone marrow cells, but 
only 2% of thymocytes. Of these latter cells about half are found at the edge of 
the medulla and the remainder are randomly distributed throughout the cortex 
and medulla. These findings lend support to the view that mature thymocytes 
leave the thymus at the cortico-medullary junction, and also suggest that both 
cortex and medulla may be sites where thymocytes mature. Biochemical studies 
showed that the MRC OX-22  antibody reacts with the high molecular weight 
form of the leukocyte-common antigen (L-CA). Comparison with data on human 
L-CA suggests that  the  molecular and  antigenic heterogeneity of this  set  of 
glycoproteins has been conserved between rat and man. 
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